sr141716 has been researched along with Acute Confusional Senile Dementia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cristino, L; Di Marzo, V; Drago, F; Leggio, GM; Micale, V; Petrosino, S; Tamburella, A | 1 |
1 review(s) available for sr141716 and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Rimonabant. SR 141716, SR 141716a.
Topics: Alzheimer Disease; Clinical Trials as Topic; Cognition Disorders; Humans; Obesity; Piperidines; Pyrazoles; Rimonabant | 2002 |
1 other study(ies) available for sr141716 and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Enhanced cognitive performance of dopamine D3 receptor "knock-out" mice in the step-through passive-avoidance test: assessing the role of the endocannabinoid/endovanilloid systems.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Anilides; Animals; Cinnamates; Cognition; Mice; Mice, Knockout; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Dopamine D3; Rimonabant; TRPV Cation Channels | 2010 |